These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 35075389

  • 1. MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway.
    Ma L, Tao C, Zhang Y.
    J Healthc Eng; 2022; 2022():7026174. PubMed ID: 35075389
    [Abstract] [Full Text] [Related]

  • 2. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X, Wen H, Jing L, Yang Y, Wang W, Liang X, Nan K, Yao Y, Tian T.
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y, He X.
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
    Jiang HW, Li L, Jiang P, Wang YF.
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4113-4122. PubMed ID: 32373947
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2.
    Zan Y, Wang B, Liang L, Deng Y, Tian T, Dai Z, Dong L.
    J Exp Clin Cancer Res; 2019 May 02; 38(1):182. PubMed ID: 31046781
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting FOXA1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway.
    Cong K, Li CG, Wei YH, Zhang K, Xu HB.
    Eur Rev Med Pharmacol Sci; 2019 Jul 02; 23(13):5730-5740. PubMed ID: 31298352
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-148a Inhibits Hepatocellular Carcinoma Cell Growth via Epithelial-to-Mesenchymal Transition and PI3K/AKT Signaling Pathways by Targeting Death Receptor-5.
    Zhang N, Zhou J, Zhou Y, Guan F.
    Appl Biochem Biotechnol; 2022 Jun 02; 194(6):2731-2746. PubMed ID: 35267120
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.
    Wu YC, Li SY, Jia YF.
    Eur Rev Med Pharmacol Sci; 2019 Oct 02; 23(20):8940-8949. PubMed ID: 31696481
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-340-5p inhibits the malignant phenotypes of osteosarcoma by directly targeting NRF2 and deactivating the PI3K/AKT pathway.
    Fan HP, Wang SY, Shi YY, Sun J.
    Eur Rev Med Pharmacol Sci; 2021 May 02; 25(10):3661-3669. PubMed ID: 34109575
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K.
    Mol Cancer; 2017 Jun 12; 16(1):103. PubMed ID: 28606154
    [Abstract] [Full Text] [Related]

  • 13. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition.
    Lu DG, Tang QL, Wei JH, He FY, Lu L, Tang YJ.
    Eur Rev Med Pharmacol Sci; 2020 Feb 12; 24(4):1656-1665. PubMed ID: 32141531
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM, Li XJ, Yang HL, Zhang YB, Li JC.
    Eur Rev Med Pharmacol Sci; 2019 Jun 12; 23(11):4688-4697. PubMed ID: 31210295
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p.
    Lu P, Jiang Y, Xia Z.
    Anticancer Drugs; 2023 Jan 01; 34(1):144-154. PubMed ID: 36539367
    [Abstract] [Full Text] [Related]

  • 17. HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway.
    Chen T, Liu R, Niu Y, Mo H, Wang H, Lu Y, Wang L, Sun L, Wang Y, Tu K, Liu Q.
    Cell Death Dis; 2021 Dec 13; 12(12):1152. PubMed ID: 34903711
    [Abstract] [Full Text] [Related]

  • 18. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL, Wang WY, Yao WQ, Li GD.
    Int J Mol Med; 2015 Dec 13; 36(6):1713-9. PubMed ID: 26499886
    [Abstract] [Full Text] [Related]

  • 19. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
    Wang X, Dong K, Jin Q, Ma Y, Yin S, Wang S.
    J Cell Biochem; 2019 Apr 13; 120(4):6781-6788. PubMed ID: 30382631
    [Abstract] [Full Text] [Related]

  • 20. miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway.
    Lv B, Liu X, Zhu X, Huang M.
    World J Surg Oncol; 2022 Jun 02; 20(1):175. PubMed ID: 35655254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.